RAD001 Plus Carboplatin in Breast Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

March 31, 2013

Conditions
Breast Cancer
Interventions
DRUG

RAD001

DRUG

Carboplatin

Trial Locations (1)

10016

NYU Clinical Cancer Center, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

NYU Langone Health

OTHER